APA (7th ed.) Citation

Yang, X., He, Z., Yuan, L., Huang, W., Li, D., Xiang, P., . . . Liu, C. (2023). Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: A protocol for a multicenter, parallel-group, randomized, controlled, open-label trial. BMC Endocrine Disorders, 23(1), 1. https://doi.org/10.1186/s12902-023-01461-9

Chicago Style (17th ed.) Citation

Yang, Xue, Zhiwei He, Li Yuan, Wenbin Huang, Doudou Li, Pingping Xiang, Yu Chen, Guofang Chen, and Chao Liu. "Remission Effect of Canagliflozin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Protocol for a Multicenter, Parallel-group, Randomized, Controlled, Open-label Trial." BMC Endocrine Disorders 23, no. 1 (2023): 1. https://doi.org/10.1186/s12902-023-01461-9.

MLA (9th ed.) Citation

Yang, Xue, et al. "Remission Effect of Canagliflozin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Protocol for a Multicenter, Parallel-group, Randomized, Controlled, Open-label Trial." BMC Endocrine Disorders, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12902-023-01461-9.